| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Oric Pharmaceuticals, Inc.'s insiders have reduced their positions by a net 111,700 shares worth roughly $1.5M. In the past 30 days, 0 insiders bought and 1 sold.
The insider who sold still holds shares after the sale.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 581.7K | $5.58M | - | |
| Dir | 241.8K | $2.32M | - | |
| Dir | 84.2K | $807.5K | - | |
| CFO | 69.8K | $669.7K | -14,000 | |
| Other | 68.1K | $653.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2021 | Carl L Gordon74 | Director | Sell | 238,282 | $30.54 | $7,275,985.53 | -8.6% | -30.5% | -78.4% | |
| Nov 4, 2020 | Topspin Fund L.P. | 10% Owner | Sell | 2,268,750 | $0.00 | - | -67.3% | - | - | |
| Apr 24, 2020 | Orbimed Advisors LLC68 | Director, 10% Owner | Buy | 281,250 | $16.00 | $4,500,000.00 | New | - | - | |
| Apr 24, 2020 | Carl L Gordon74 | Director, 10% Owner | Buy | 281,250 | $16.00 | $4,500,000.00 | New | - | - |